A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. - Wikidata - wikimedia - TriplyDB

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

http://www.wikidata.org/entity/Q44613177

about

Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women Tamoxifen in early-stage estrogen receptor-positive breast cancer: overview of clinical use and molecular biomarkers for patient selection Tamoxifen: catalyst for the change to targeted therapy Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer 26th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA, 3-6 December 2003: update on clinical research Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives.Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogens Letrozole sensitizes breast cancer cells to ionizing radiation Clinical trial update: National Cancer Institute of Canada Report on the 4th European Breast Cancer Conference, Hamburg, Germany, 16-20 March 2004 When clinical trials are compromised: a perspective from a patient advocate Early stopping of clinical trials Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions.Challenges in translating endpoints from trials to observational cohort studies in oncology Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective Statistical controversies in clinical research: long-term follow-up of clinical trials in cancer Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem Progress in adjuvant chemotherapy for breast cancer: an overview Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonance Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline Exemestane for breast cancer prevention: a critical shift?Breast cancer chemoprevention: progress and controversy.Breast cancer chemoprevention: old and new approaches Adjuvant treatment for older women with invasive breast cancer Acupuncture for treating aromatase inhibitor-related arthralgia in breast cancer: a systematic review and meta-analysis The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.Adjuvant therapy use among Appalachian breast cancer survivors Bazedoxifene exhibits antiestrogenic activity in animal models of tamoxifen-resistant breast cancer: implications for treatment of advanced disease.Mechanisms of acquired resistance to endocrine therapy in hormone-dependent breast cancer cells.Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial.Breast cancer (non-metastatic)Current strategies for the prevention of breast cancer Prevention, diagnosis and treatment of osteoporosis following menopause induced due to oncological disease.

P2860

Q24194371-3A096903-4086-4A4B-80E4-AA644540C79B Q24605762-5E1220D5-573C-47C9-806E-FCD767AEAD83 Q24652988-DC2CCF55-1FEC-471E-8D7A-A111FC821F7D Q24670339-C9614757-9126-415D-A1A6-53FB9AE22696 Q24794435-07FEAEB7-A6C9-41FB-B192-89D20637B775 Q24796185-A06A6A7D-421D-4A2F-84C4-8EFC4B6DBCAD Q24796233-11BA1ED0-1694-447E-B526-EFB45F335984 Q24797004-2B95D36D-FC09-46CE-AAB2-64166AE5EA74 Q24797524-3D36CC3C-6D72-46F9-AF90-FCFE5530E2AB Q24806223-0938A5FF-43FA-4FB7-B678-0505467A5AE3 Q24812087-2E14B55D-A8DA-437B-A03F-20C9AAAAB80E Q24813532-F0189121-693C-4409-A7C9-C854AC8AEA3B Q25256598-E8444135-7C50-4DF8-AC3F-06A4B5AF0330 Q25257621-01BC55CA-BC08-47D0-BEDC-3F84B7FBBC5C Q25257781-7B7A15BE-669C-4AC9-B274-6CC93EB00FE5 Q26746190-7759DFD6-2FC1-4F95-A772-528E4523044D Q26746212-0FCAD0EB-8302-4746-82BE-AA16D5697C67 Q26752834-5EA550BB-DD77-4296-8E21-28F06AFDD78F Q26782494-43A84515-22B8-4A2F-9713-75301413A4C5 Q26782584-787A9629-C190-48A3-BB00-081AA22B3795 Q26798078-0CD47ABA-476F-42FA-A7AD-BA4ABB273DC8 Q26859193-A710083C-0695-4714-A8B0-0B981E663B06 Q27002430-BF3B5044-4FD8-4844-BE7B-917BF5CD8041 Q27028211-E3004201-1096-46D9-A806-385A6DEC9157 Q27692587-6D1E117F-F298-46CD-8C97-A4E27DEF3F7B Q27693259-C82388AD-6B3F-44EC-B575-966A7C632CB6 Q28066744-FE6A2E85-A556-4EAF-86CE-1694A99E1DEA Q28087204-F27D0A34-436B-4D82-B12D-6953814B4C65 Q28217652-406489BA-F09A-4DA2-89E8-3062CDB1D93A Q29011698-81D21437-ECF8-4493-A638-481B0853AC7A Q30275126-7FDF4681-27A6-46F9-A582-BF03179D63CB Q30275906-A5442A56-F336-4962-B669-9AE157D3C034 Q30279083-D26F40E1-792E-4BE6-8F69-1E16BFE90E92 Q30413295-27E782F5-F1CB-4320-9CF2-1E7155A0A0AD Q30441321-A70EBF6D-B25E-428E-B4D9-1953A9A51A24 Q30543788-F6F788FB-99FC-4810-BA1C-95B75D506DFB Q30860467-9E5636E7-BAD3-4C37-865D-582BB38C476E Q33446778-4A780ADA-732B-4982-9FB7-675B02F63640 Q33599463-C2CBD400-D4C0-4B97-9856-88D5B943413F Q33610328-C1B2A4FE-87AC-426F-8382-ABD167F24718

P2860

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

http://www.wikidata.org/entity/Q44613177

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

A randomized trial of letrozol ...... for early-stage breast cancer.

@en

A randomized trial of letrozol ...... for early-stage breast cancer.

@nl

type

label

A randomized trial of letrozol ...... for early-stage breast cancer.

@en

A randomized trial of letrozol ...... for early-stage breast cancer.

@nl

prefLabel

A randomized trial of letrozol ...... for early-stage breast cancer.

@en

A randomized trial of letrozol ...... for early-stage breast cancer.

@nl

P1433

Q44613177-DF0630CA-E7DF-45BE-ACDC-2F61FF5DCDDD

P1476

Q44613177-828B6EB6-FF3D-4A85-B83F-2D9F5A2DA015

P2093

Q44613177-02423740-0737-4810-A5A6-88A625517508

Q44613177-1165E292-A443-48B4-91CD-8E403DE6AA34

Q44613177-11EB0317-1D2B-4618-8627-0258BB51F819

Q44613177-3246AC06-B57D-47BE-989A-426213948616

Q44613177-331182FC-60BD-45D7-8DAE-FFEEF5264F33

Q44613177-39A36DDA-1782-4489-A087-4CDE862A78FD

Q44613177-5D24DE30-E4B4-402B-8CDA-99D173FD0463

Q44613177-6DEC7F72-93FE-459A-BAEF-2E401AA7D86C

Q44613177-84E2842B-42FC-4477-8C7C-4F933F8C2DF0

Q44613177-87694C60-4AF0-4748-858C-F077402E1117

P304

Q44613177-8CD5A2B5-A578-4E4E-AA99-EAF8143EC03D

P31

Q44613177-39E06830-49D2-4ECE-9871-1FB3DF671FB2

P356

Q44613177-5085C916-B445-4BD4-B100-C94E1F26F440

P407

Q44613177-082D5520-D943-4D38-8FA7-3130E04616E9

P433

Q44613177-DD2CEFB7-2526-4A1E-9E75-D980500FAD0B

P478

Q44613177-06492120-F93E-421E-9065-94CE9C7A3566

P50

Q44613177-F0BB0B38-4FB6-47BA-A0BE-4FE9A87B171F

P577

Q44613177-088E5D91-9888-4C30-A108-0C1B8709EB39

P698

Q44613177-51C43BFA-2383-4C7B-AA4E-BFB09509613E

Q44613177-dbb5d14b-0c88-4b13-90c2-b1b1cd5ccba2

P356

P1433

The New England Journal of Medicine

P1476

A randomized trial of letrozol ...... for early-stage breast cancer.

@en

P2093

Dongsheng Tu

http://www.w3.org/2001/XMLSchema#string

Edith A Perez

http://www.w3.org/2001/XMLSchema#string

Hyman B Muss

http://www.w3.org/2001/XMLSchema#string

James N Ingle

http://www.w3.org/2001/XMLSchema#string

Jeffrey S Abrams

http://www.w3.org/2001/XMLSchema#string

Joseph L Pater

http://www.w3.org/2001/XMLSchema#string

Kathleen I Pritchard

http://www.w3.org/2001/XMLSchema#string

Lois E Shepherd

http://www.w3.org/2001/XMLSchema#string

Martine J Piccart

http://www.w3.org/2001/XMLSchema#string

Michael J Palmer

http://www.w3.org/2001/XMLSchema#string

P304

1793-1802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA032312

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14551341

http://www.w3.org/2001/XMLSchema#string